✦ LIBER ✦

Ulceration and stage are predictive of interferon efficacy in melanoma: Results of the phase III adjuvant trials EORTC 18952 and EORTC 18991

✍ Scribed by Alexander M.M. Eggermont; Stefan Suciu; Alessandro Testori; Wim H. Kruit; Jeremy Marsden; Cornelis J. Punt; Mario Santinami; François Salès; Dirk Schadendorf; Poulam Patel; Reinhard Dummer; Caroline Robert; Ulrich Keilholz; Antoine Yver; Alan Spatz

Book ID: 116430895
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 373 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2011.09.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

G5 Ulceration of primary melanoma and re

G5 Ulceration of primary melanoma and responsiveness to adjuvant interferon therapy: Analysis of the adjuvant trials EORTC18952 and EORTC18991 in 2,644 patients

✍ A.M.M. Eggermont; S. Suciu; A. Testori; P. Patel; A. Spatz 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Adjuvant therapy with pegylated interfer

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

✍ Alexander MM Eggermont; Stefan Suciu; Mario Santinami; Alessandro Testori; Wim H 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 236 KB

5LB Prognostic value of autoantibodies i

5LB Prognostic value of autoantibodies in melanoma stage III patients in the EORTC 18991 phase III randomized trial comparing adjuvant pegylated interferon α2b vs observation

✍ M.G. Bouwhuis; S. Suciu; A. Testori; M. Santinami; W.H. Kruit; C.J. Punt; F. Sal 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Serum concentrations of pegylated interf

Serum concentrations of pegylated interferon α-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon α-2b in a randomized phase III trial (EORTC 18991)

✍ Alexander M. M. Eggermont; Marna G. Bouwhuis; Wim H. Kruit; Alessandro Testori; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 341 KB

6LBA The benefit of regional irradiation

6LBA The benefit of regional irradiation in stage I–III breast cancer: 10 years results of the EORTC ROG and BCG phase III trial 22922/10925

✍ Struikmans, H.; Collette, S.; Van den Bogaert, W.; Kirkove, C.; Budach, V.; Main 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Efficacy and safety of bexarotene combin

Efficacy and safety of bexarotene combined with psoralen–ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB–IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial 21011 (NCT00056056)

✍ S. Whittaker; P. Ortiz; R. Dummer; A. Ranki; B. Hasan; B. Meulemans; S. Gellrich 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB